| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458709 | Radiotherapy and Oncology | 2018 | 5 Pages |
Abstract
This is the first study to examine a group of patients treated with a Dmin ranging from 0â¯Gy toâ¯>250â¯Gy. Treatment with a Dmin of 65â¯Gy is necessary to achieve durable tumor response. The dose-response data provided by our study could be used for the design of future trials examining the ideal dose for the treatment of choroidal melanoma with brachytherapy or charged particle external beam radiotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alex De Caluwé, Karolien Termote, Dirk Van Gestel, Erik Van Limbergen,